We are a startup research and development company that develops novel early DNA methylation markers in blood for detecting cancers. Early detection of cancer can save many lives. Our technology is based on epigenetic principles.
Technology
Breakthrough High-Throughput Test for Early Detection of Hepatocellular Carcinoma Developed by HKG Epitherapeutics Ltd and Partners international journal Nature com. (https://www.nature.com/articles/s41467-023-39055-7)
